PDI, TMAC form a strategic alliance
Saddle River, NJ-based PDI is a provider of sales and marketing support to US pharmaceutical companies, and TMAC, based in Keenesaw, GA, provides customized medical science liaison (MSL) and medical affairs services.
Under the exclusive agreement, PDI and TMAC will integrate their service offerings to benefit client brands, participate in joint client presentations and exchange new business leads.
By operating under this agreement, both PDI and TMAC are better able to meet a wider variety of client demands for best-in-class field resources, while preserving the important separation of pharma sales and medical departments.
Nancy Lurker, CEO, PDI, said that MSL plays an increasingly crucial role in pharmaceuticals today—that of providing high-level scientific information to key opinion leaders and other medical doctors on a peer-to-peer basis. She added that the company is very pleased to partner with TMAC through this strategic alliance.
Lurker noted that agreement will increase “PDI's ability to provide maximum value to our clients and fills a critical need for a higher science personal engagement with physicians.”
TMAC CEO Evan Demestihas, MD, said the agreement will give each company even greater leverage to build their business in the industry. Demestihas noted that with the partnership, each company gains a more complete suite of field services, placing them in a better position to seize growth opportunities.
PDI was one of the first contract services organizations to provide sales and marketing support to established and emerging US-based biopharmaceutical companies.